Lifestyle Education and Glucose Monitoring Using FreeStyle Libre
in Adults with Type 2 Diabetes and Moderate Blood Sugar Control
Led by Seoul National University Hospital · Updated on 2021-06-21
126
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of medical nutritional therapy combined with glucose monitoring methods in patients with type 2 diabetes who are on oral hypoglycemic agents or basal insulin only. This randomized, open-label, controlled study focuses on individuals with type 2 diabetes who have an HbA1c between 7.0% and 10.0%, aiming to compare the impact of continuous glucose monitoring versus self-monitoring of blood glucose on glycemic control.
The study involves 126 participants randomized equally into two groups. One group will use the FreeStyle Libre continuous glucose monitoring device for 12 weeks alongside education on lifestyle modification. The other group will use a traditional blood glucose meter combined with similar lifestyle education. Both groups will receive structured phone reminders every 4 weeks to support adherence. After 12 weeks, participants will return for final laboratory tests and surveys.
Participants will attend baseline and 12-week follow-up visits including laboratory examinations such as HbA1c measurement and surveys on diabetes self-care activities. Researchers will monitor changes in HbA1c, fasting glucose, body weight, blood pressure, waist circumference, lipid levels, and self-care behaviors. The study aims to assess how different glucose monitoring methods influence diabetes management over the 3-month period.
CONDITIONS
Brief Title
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
Research Team
H
Hun Jee Choe, MD
Y
Young Min Cho, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Uncontrolled type 2 diabetes with HbA1c between 7.0% and 10.0%
Signed informed consent
You will not qualify if you...
Diagnosis of other types of diabetes mellitus, such as type 1 diabetes
Use of prandial insulin
Change in diabetes medication within the last 3 months
Pregnant or lactating women
Addiction to drugs or alcohol
Use of medications causing drug-induced high blood sugar, such as steroids
Severe liver disease
End-stage kidney disease requiring dialysis
Unable to wear continuous glucose monitoring devices due to skin problems
Conditions affecting the stability of HbA1c measurement
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Treatment
Duration - 12 weeks
Participants use either the FreeStyle Libre continuous glucose monitoring device or a blood glucose meter along with personalized education on lifestyle modification. Structured phone visits occur every 4 weeks to provide reminders and support.
1 baseline visit and monthly phone visits every 4 weeks
Follow-up
Duration - At 12 weeks after treatment start
Participants complete the study with a final visit including laboratory examinations and surveys to assess changes from baseline.
1 final visit (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of Daily Movement and Lifestyle Patterns in Adults with Type 2 Diabetes Compared to Healthy Adults
Phase 12a Study Evaluating Safety and Effects of ARO-ALK7 in Adults With Obesity, With or Without Type 2 Diabetes
Comparing Empagliflozin and Dapagliflozin for Treatment of Type 2 Diabetes, Chronic Kidney Disease, and Heart Failure Using Cluster Randomization in Electronic Health Records
Comparing Enavogliflozin With Other SGLT2 Inhibitors for Heart and Kidney Health in Adults With Type 2 Diabetes
Comparing Cleerly Coronary Artery Disease Stage-Based Care With Risk Factor-Based Care to Prevent Cardiovascular Events
Heart Disease Risk Study in Adults Aged 40 to 69 Newly Diagnosed with Type 2 Diabetes in Southeast Asia
Evaluating Once-Weekly Subcutaneous NNC0662-0419 Compared to Semaglutide and Placebo for Adults with Type 2 Diabetes
Evaluating the Safety and Effectiveness of Weekly UBT251 Injections Compared to Semaglutide in Adults with Type 2 Diabetes
Phase 1 Study to Test Safety and Tolerability of NNC1679-0001 in Healthy Adults and Adults With Type 2 Diabetes
Study of Weekly CagriSema Injections Compared to Placebo for Blood Sugar and Weight Control in Children and Adolescents with Type 2 Diabetes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study.